BioAdaptives Inc. (BDPT)
BioAdaptives Inc. operates in the Packaged Foods industry of the Consumer Defensive sector, headquartered in Las Vegas, NV, US. The stock last traded at $0.00, down 5.56% on the session, giving a market capitalisation of $20,415. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of -6186.9%. Its beta of 1.29 implies it has historically moved more than the broad market.
BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers Human Clinical trial; Zeranovia, a natural ingredient and uses proprietary methods of optimizing the availability of nutrients in foods and beverages; Lung Flute, a medical device; and Xcellara, PawPa, and MyndMed. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. The company was incorporated in 2013 and is based in Las Vegas, Nevada.
BioAdaptives Inc. is most often compared with the following Consumer Defensive names: